Literature DB >> 35951253

Effects of Training on Use of Stimulant Diversion Prevention Strategies by Pediatric Primary Care Providers: Results from a Cluster-Randomized Trial.

Elizabeth A McGuier1, David J Kolko2, Sarah L Pedersen2, Heidi L Kipp3, Heather M Joseph2, Rachel A Lindstrom2, Daniel J Bauer4, Geetha A Subramaniam5, Brooke S G Molina2.   

Abstract

Pediatric primary care is a promising setting for reducing diversion of stimulant medications for ADHD. We tested if training pediatric primary care providers (PCPs) increased use of diversion prevention strategies with adolescents with ADHD. The study was a cluster-randomized trial in 7 pediatric primary care practices. Participants were pediatric PCPs (N = 76) at participating practices. Practices were randomized to a 1-h training in stimulant diversion prevention or treatment-as-usual. At baseline, 6 months, 12 months, and 18 months, PCPs rated how often they used four categories of strategies: patient/family education, medication management/monitoring, assessment of mental health symptoms/functioning, and assessment of risky behaviors. They completed measures of attitudes, implementation climate, knowledge/skill, and resource constraints. Generalized Estimating Equations estimated differences in outcomes by condition. Mediation analyses tested if changes in knowledge/skill mediated training effects on strategy use. PCPs in the intervention condition reported significantly greater use of patient/family education strategies at all follow-up time points. There were no differences between conditions in medication management, assessment of mental health symptoms/functioning, or assessment of risky behaviors. At 6 months, PCPs in the intervention condition reported more positive attitudes toward diversion prevention, stronger implementation climate, greater knowledge/skill, and less resource constraints. Differences in knowledge/skill persisted at 12 months and 18 months. Brief training in stimulant diversion had substantial and enduring effects on PCPs' self-reported knowledge/skill and use of patient/family education strategies to prevent diversion. Training had modest effects on attitudes, implementation climate, and resource constraints and did not change use of strategies related to medication management and assessment of mental health symptoms/functioning and risky behaviors. Changes in knowledge/skill accounted for 49% of the total effect of training on use of patient/family education strategies. Trial registration This trial is registered on ClinicalTrials.gov (NCT03080259). Posted March 15, 2017.
© 2022. Society for Prevention Research.

Entities:  

Keywords:  Clinical trial; Implementation; Pediatric primary care; Stimulant diversion; Stimulant misuse

Mesh:

Year:  2022        PMID: 35951253      PMCID: PMC9489672          DOI: 10.1007/s11121-022-01411-2

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  27 in total

1.  Diversion of prescription stimulant drugs among 10-18-year-olds.

Authors:  Sonam O Lasopa; Catherine W Striley; Linda B Cottler
Journal:  Curr Opin Psychiatry       Date:  2015-07       Impact factor: 4.741

2.  Stimulant Diversion Risk Among College Students Treated for ADHD: Primary Care Provider Prevention Training.

Authors:  Brooke S G Molina; Heidi L Kipp; Heather M Joseph; Stacey A Engster; Seth C Harty; Montaya Dawkins; Rachel A Lindstrom; Daniel J Bauer; Srihari S Bangalore
Journal:  Acad Pediatr       Date:  2019-06-08       Impact factor: 3.107

3.  Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Authors:  Mark L Wolraich; Joseph F Hagan; Carla Allan; Eugenia Chan; Dale Davison; Marian Earls; Steven W Evans; Susan K Flinn; Tanya Froehlich; Jennifer Frost; Joseph R Holbrook; Christoph Ulrich Lehmann; Herschel Robert Lessin; Kymika Okechukwu; Karen L Pierce; Jonathan D Winner; William Zurhellen
Journal:  Pediatrics       Date:  2019-10       Impact factor: 7.124

4.  Physician practices to prevent ADHD stimulant diversion and misuse.

Authors:  Natalie Colaneri; Sarah Keim; Andrew Adesman
Journal:  J Subst Abuse Treat       Date:  2016-12-21

5.  Physician "costs" in providing behavioral health in primary care.

Authors:  Tawnya Meadows; Rachel Valleley; Mary Kelly Haack; Ryan Thorson; Joseph Evans
Journal:  Clin Pediatr (Phila)       Date:  2010-12-30       Impact factor: 1.168

6.  Physician Training and Qualification to Educate Patients on Attention-Deficit/Hyperactivity Disorder Stimulant Diversion and Misuse.

Authors:  Natalie Colaneri; Sarah A Keim; Andrew Adesman
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-08-20       Impact factor: 2.576

7.  Medical and nonmedical use of prescription stimulants: results from a national multicohort study.

Authors:  Sean Esteban McCabe; Brady T West
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-09-23       Impact factor: 8.829

8.  Barriers to the Identification and Management of Psychosocial Problems: Changes From 2004 to 2013.

Authors:  Sarah McCue Horwitz; Amy Storfer-Isser; Bonnie D Kerker; Moira Szilagyi; Andrew Garner; Karen G O'Connor; Kimberly E Hoagwood; Ruth E K Stein
Journal:  Acad Pediatr       Date:  2015-09-26       Impact factor: 3.107

9.  Assessing implementation difficulties in tobacco use prevention and cessation counselling among dental providers.

Authors:  Masamitsu Amemori; Susan Michie; Tellervo Korhonen; Heikki Murtomaa; Taru H Kinnunen
Journal:  Implement Sci       Date:  2011-05-26       Impact factor: 7.327

10.  Adolescents Treated for Attention-Deficit/Hyperactivity Disorder in Pediatric Primary Care: Characterizing Risk for Stimulant Diversion.

Authors:  Brooke S G Molina; Heather M Joseph; Heidi L Kipp; Rachel A Lindstrom; Sarah L Pedersen; David J Kolko; Daniel J Bauer; Geetha A Subramaniam
Journal:  J Dev Behav Pediatr       Date:  2021-09-01       Impact factor: 2.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.